Home / Companies / News / Dabur's aggressive focus on healthcare products is paying off

Dabur's aggressive focus on healthcare products is paying off

Segment supported performance in Q1, which saw revenue decline by 12.9% and PBT by 8.5%

Premium

Dabur's specially-designed vans are moving around residential localities across India, reaching out to consumers educating them about the need to boost immunity to fight illnesses

Shreepad S Aute Mumbai

3 min read Last Updated : Jul 30 2020 | 10:28 PM IST

At a time when the non-food FMCG (fast-moving consumer goods) category has been severely impacted, Dabur not only reported better-than-estimated volumes in the June quarter of financial year 2020-21 (Q1FY21), but it saw an improvement over the previous quarter.

Compared to a decline of 14.6 per cent in volumes in Q4FY20 and similar expectations for Q1, Dabur’s domestic volumes were down only 9.7 per cent in the recently concluded quarter. Dabur is among the few FMCG players to have reported a sequential improvement in volumes in Q1, which was badly affected by the lockdown. The improvement was led by the company’s

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in